Johnson & Johnson (NYSE: JNJ) last traded at $270.24, up 1.07% on the session. The quote above updates while this page is open; the figures below are drawn from Johnson & Johnson’s own filings and are restated only when a new one is published.
Johnson & Johnson trades on NYSE under the ticker JNJ. It is classified in the Healthcare sector, Pharmaceuticals industry. Its market capitalisation is $651.25 billion.
Healthcare sectorPharmaceuticalsListed on NYSE
Valuation measures for Johnson & Johnson, derived from the latest quote and its most recent SEC filing.
| Market cap | $651.25B |
|---|---|
| Enterprise value | $746.92B |
| P/E ratio | 31.39 |
| Price / sales | 6.65 |
| Price / book | 7.66 |
| Beta | -0.20 |
Trailing-twelve-month figures tagged in Johnson & Johnson's XBRL filings with the SEC.
| Revenue (TTM) | $97.93B |
|---|---|
| Net income (TTM) | $21.04B |
| EPS (TTM) | $8.61 |
| Gross margin | 67.91% |
| Return on equity | 24.76% |
| Cash | $20.42B |
Range and volume for JNJ over the past 52 weeks.
| 52-week high | $276.47 |
|---|---|
| 52-week low | $173.33 |
| Volume | 6.18M |
| Average volume | 7.98M |
| Previous close | $267.37 |
Other Healthcare companies tracked on FurlPay Markets.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.